A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family

Human Immunology

Volumn 73, Issue 8, 2012, Pages 836-839

  Lougaris, V ^a   Gallizzi, R ^b   Vitali, M ^a   Baronio, M ^a   Salpietro, A ^b   Bergbreiter, A ^c   Salzer, U ^c   Badolato, R ^a   Plebani, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; EPSTEIN BARR VIRUS; FOOD ALLERGY; GASTROINTESTINAL INFECTION; GENE MUTATION; HETEROZYGOSITY; HUMAN; IMMUNOGLOBULIN DEFICIENCY; ITALY; LOWER RESPIRATORY TRACT INFECTION; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECURRENT INFECTION; SCHOOL CHILD; SIBLING; UPPER RESPIRATORY TRACT INFECTION;

AGAMMAGLOBULINEMIA; B-LYMPHOCYTES; BASE SEQUENCE; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; RESPIRATORY TRACT INFECTIONS; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84864042109     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.05.001     Document Type: Article

References (14)

1. Janeway C.A., Apt L., Gitlin D. Agammaglobulinemia. Trans Assoc Am Physicians 1953, 66:200-202.
2. Salzer U., Maul-Pavicic A., Cunningham-Rundles C., Urschel S., Belohradsky B.H., Litzman J., Holm A., Franco J.L., Plebani A., Hammarstrom L., Skrabl A., Schwinger W., Grimbacher B. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004, 113(3):234-240.
3. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., Geha R.S. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37(8):829-834.
4. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarström Q., Schmitt-Graeff A., Schlesier M., Peter H.H., Rockstroh J.K., Schneider P., Schäffer A.A., Hammarström L., Grimbacher B. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37(8):820-828.
5. Warnatz K., Salzer U., Rizzi M., Fischer B., Gutenberger S., Böhm J., Kienzler A.K., Pan-Hammarström Q., Hammarström L., Rakhmanov M., Schlesier M., Grimbacher B., Peter H.H., Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106(33):13945-13950.
6. van Zelm M.C., Reisli I., van der Burg M., Castaño D., van Noesel C.J., van Tol M.J., Woellner C., Grimbacher B., Patiño P.J., van Dongen J.J., Franco J.L. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Eng J Med 2006, 354(18):1901-1912.
7. van Zelm M.C., Smet J., Adams B., Mascart F., Schandené L., Janssen F., Ferster A., Kuo C.C., Levy S., van Dongen J.J., van der Burg M. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010, 120(4):1265-1274.
8. Kuijpers T.W., Bende R.J., Baars P.A., Grummels A., Derks I.A., Dolman K.M., Beaumont T., Tedder T.F., van Noesel C.J., Eldering E. Van Lier RA.CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010, 120(1):214-222.
9. Sekine H., Ferreira R.C., Pan-Hammarström Q., Graham R.R., Ziemba B., de Vries S.S., Liu J., Hippen K., Koeuth T., Ortmann W., Iwahori A., Elliott M.K., Offer S., Skon C., Novitzke J., Lee A.T., Zhao N., Tompkins J.D., Altshuler D., Gregersen P.K., Cunningham-Rundles C., Harris R.S., Her C., Nelson D.L., Hammarström L., Gilkenson G.S., Behrens T.W. Role for Msh5 in the regulation of Ig class switch recombination. PNAS 2007, 104(17):7193-7198.
10. Salzer U., Bacchelli C., Buckridge S., Pan-Hammarström Q., Jennings S., Lougaris V., Bergbreiter A., Hagena T., Birmelin J., Plebani A., Webster A.D., Peter H.H., Suez D., Chapel H., McLean-Tooke A., Spickett G.P., Anover-Sombke S., Ochs H.D., Urschel S., Belohradsky B.H., Ugrinovic S., Kumararatne D.S., Lawrence T.C., Holm A.M., Franco J.L., Schulze I., Schneider P., Gertz E.M., Schäffer A.A., Hammarström L., Thrasher A.J., Gaspar H.B., Grimbacher B. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009, 113(9):1967-1976.
11. Mohammadi J., Liu C., Aghamohammadi A., Bergbreiter A., Du L., Lu J., Rezaei N., Amirzargar A.A., Moin M., Salzer U., Pan-Hammarström Q., Hammarström L. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol 2009 Nov, 29(6):777-785.
12. Bacchelli C., Buckland K.F., Buckridge S., Salzer U., Schneider P., Thrasher A.J., Gaspar H.B. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. J Allergy Clin Immunol 2011 May, 127(5):1253-1259.
13. Lee J.J., Jabara H.H., Garibyan L., Rauter I., Sannikova T., Dillon S.R., Bram R., Geha R.S. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol 2010 Dec, 126(6):1234-1241.
14. Lee J.J., Rauter I., Garibyan L., Ozcan E., Sannikova T., Dillon S.R., Cruz A.C., Siegel R.M., Bram R., Jabara H., Geha R.S. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood 2009, 114(11):2254-2262.